Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation
Josh Levitsky(Northwestern University), Michaël Abécassis(University of Arizona), Anthony J. Demetris(University of Pittsburgh Medical Center), Manoj Kandpal(Northwestern University), Sunil M. Kurian(Scripps Clinic), Thomas D. Schiano(Icahn School of Medicine at Mount Sinai), Sumeet K. Asrani(Baylor University Medical Center), Charles M. Miller(Great Ormond Street Hospital for Children NHS Foundation Trust), Lihui Zhao(University of Shanghai for Science and Technology), Kenneth D. Chavin(University Hospitals of Cleveland), Adyr A. Moss(Mayo Clinic Hospital), Merideth Brown(National Institute of Allergy and Infectious Diseases), Brian Armstrong(Rho (United States)), Kexin Guo(Northwestern University), Nancy D. Bridges(National Institute of Allergy and Infectious Diseases)
Cited by 43
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
|Liver Transplantation|2010|1.2k